Business Description
Medclair AB
ISIN : SE0009190572
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 69.62 | |||||
Equity-to-Asset | 0.79 | |||||
Debt-to-EBITDA | 0.05 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 6.84 | |||||
Beneish M-Score | -2.12 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 78.8 | |||||
3-Year EPS without NRI Growth Rate | -7.7 | |||||
3-Year Book Growth Rate | 8.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 30.71 | |||||
9-Day RSI | 33 | |||||
14-Day RSI | 34.88 | |||||
6-1 Month Momentum % | 45.42 | |||||
12-1 Month Momentum % | 9.2 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.88 | |||||
Quick Ratio | 1.42 | |||||
Cash Ratio | 0.71 | |||||
Days Inventory | 195.63 | |||||
Days Sales Outstanding | 49.53 | |||||
Days Payable | 100.35 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.3 | |||||
Shareholder Yield % | 0.36 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 61.65 | |||||
Operating Margin % | -5.78 | |||||
Net Margin % | 5.16 | |||||
FCF Margin % | 18.09 | |||||
ROE % | 4.74 | |||||
ROA % | 3.95 | |||||
ROIC % | -5.13 | |||||
3-Year ROIIC % | -7.6 | |||||
ROC (Joel Greenblatt) % | -22.44 | |||||
ROCE % | -4.91 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 45.26 | |||||
PE Ratio without NRI | 45.26 | |||||
Price-to-Owner-Earnings | 43.16 | |||||
PS Ratio | 2.7 | |||||
PB Ratio | 2.37 | |||||
Price-to-Tangible-Book | 5.88 | |||||
Price-to-Free-Cash-Flow | 17.9 | |||||
Price-to-Operating-Cash-Flow | 17.9 | |||||
EV-to-EBIT | -44.21 | |||||
EV-to-EBITDA | 35.89 | |||||
EV-to-Revenue | 2.37 | |||||
EV-to-FCF | 14.71 | |||||
Price-to-Graham-Number | 3.42 | |||||
Price-to-Net-Current-Asset-Value | 9.8 | |||||
Earnings Yield (Greenblatt) % | -2.26 | |||||
FCF Yield % | 7.04 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Medclair AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 47.153 | ||
EPS (TTM) (kr) | 0.034 | ||
Beta | 0 | ||
Volatility % | 60.86 | ||
14-Day RSI | 34.88 | ||
14-Day ATR (kr) | 0.140872 | ||
20-Day SMA (kr) | 1.62925 | ||
12-1 Month Momentum % | 9.2 | ||
52-Week Range (kr) | 1.045 - 2.59 | ||
Shares Outstanding (Mil) | 82.49 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Medclair AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Medclair AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Medclair AB Frequently Asked Questions
What is Medclair AB(NGM:MCLR)'s stock price today?
When is next earnings date of Medclair AB(NGM:MCLR)?
Does Medclair AB(NGM:MCLR) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |